Sodium-Glucose Cotransporter 2 Inhibitors Protect the Heart
TUESDAY, Feb. 18, 2020 -- Sodium-glucose cotransporter 2 inhibitors protect against cardiovascular disease in patients with type 2 diabetes, according to a review published in the Feb. 4 issue of the Journal of the American Heart Association.
Clare...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Pharmaceuticals | Sodium